The Food and Drug Administration (FDA) has approved three GLP-1s for obesity-related treatment, including Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
The side effect profiles of semaglutide vs tirzepatide differ in several ways, and injection site reactions are one area where individual response varies significantly between the two medications
If side effects are severe (persistent vomiting, signs of pancreatitis, vision changes), stop the medication and contact your prescriber immediately
Any researcher who purchased products from Paradigm Peptides should verify those products through independent testing before use
You may now give a serious thought about taking L-carnitine supplements
Keep a Record: Write down your heart rate readings